HD-tDCS + Speech Therapy for Aphasia
Trial Summary
What is the purpose of this trial?
This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment HD-tDCS + Speech Therapy for Aphasia?
Research shows that combining transcranial direct current stimulation (tDCS) with speech therapy can help improve language skills in people with aphasia after a stroke. Studies have found that this combination can lead to better language comprehension and production, offering promising results for recovery.12345
Is the combination of transcranial direct current stimulation (tDCS) and speech therapy safe for humans?
How does the HD-tDCS + Speech Therapy treatment for aphasia differ from other treatments?
The HD-tDCS + Speech Therapy treatment is unique because it combines transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, with traditional speech therapy to enhance brain plasticity and improve language recovery in aphasia patients. This approach aims to boost the effectiveness of speech therapy by facilitating brain activity, offering a novel strategy compared to standard speech therapies alone.1391011
Research Team
Eligibility Criteria
This trial is for adults over 18 with aphasia from left-sided brain damage like a stroke, who can speak English and are MRI-eligible. It's not for those with advanced neurodegenerative diseases, unmanaged seizure disorders, severe mental health issues, major hearing or vision problems, developmental disabilities, or MRI contraindications such as metal implants.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Cycle A
Participants receive targeted anodal-tDCS or sham-tDCS along with speech therapy for 10 sessions
Assessment and Crossover
Participants undergo behavioral assessment and fMRI before crossing over to receive the alternate tDCS intervention
Treatment Cycle B
Participants receive the alternate tDCS intervention along with the same speech therapy arm for another 10 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment with behavioral assessments and fMRI at 3 and 6 months post Treatment Cycle B
Treatment Details
Interventions
- Speech Therapy (Behavioral Intervention)
- Targeted Transcranial Direct Current Stimulation (Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor